Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7301
    +0.0003 (+0.04%)
     

  • CRUDE OIL

    82.78
    -0.03 (-0.04%)
     

  • Bitcoin CAD

    88,096.30
    -3,139.27 (-3.44%)
     

  • CMC Crypto 200

    1,386.76
    -37.34 (-2.62%)
     

  • GOLD FUTURES

    2,320.80
    -17.60 (-0.75%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,462.00
    -202.50 (-1.15%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     

  • CAD/EUR

    0.6817
    -0.0002 (-0.03%)
     

Ceapro, Inc. :CZO-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 22, 2017

CapitalCube
Updated
Ceapro, Inc. :CZO-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 22, 2017

Categories: Yahoo FinanceGet free summary analysis Ceapro, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Ceapro, Inc. – ProMetic Life Sciences Inc., GeneNews Limited and Medicure Inc. (PLI-CA, GEN-CA and MPH-CA) that have also reported for this period. Highlights Summary numbers: Revenues of CAD ... Read more (Read more...)

Continue reading